HealthCare Global – the value unlocking story

Analysis of this story by ValuePickr · 15 Mar 2026, 6:08 PM IST (about 2 months ago)

BULLISH(90%)

sell

AI Analysis

The healthcare sector, especially specialized segments like oncology and fertility, is experiencing significant growth in India. HCG's established presence and scalable model position it well.

Trading Insight

Positive outlook for HCG; investors could look for entry points, considering its strong fundamentals and growth prospects in a defensive sector.

Quick check: HCG neutral, MARUTI bearish bias (oversold).

Key Evidence

•Healthcare Global Enterprises (HCG) is a leading cancer care hospital chain.
•Operates 24 facilities including 18 cancer centres, with 1364 beds and 200+ oncologists.
•Entered fertility segment by acquiring BACC Healthcare (Milann brand).
•Cancer care and fertility segments accounted for 92% and 8% of FY17 revenues respectively.
•Employs a 'Hub & Spoke' business model for scalability.